Caris Life SciencesCAI
NASDAQMedical Laboratories
$28.52+0.42%
No cached AI snapshot yet for CAI.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
$5.89BMarket cap
$56.0152-week high
$16.2852-week low
2,309,704Avg volume (30d)
1,846 employees282.58M shares outstandinglisted 2025-06-18dividend yield 6.51%
Next earnings ~May 5, 2026 · Ex-dividend Sep 9, 2021 · Dividend $0.30 quarterly
About Caris Life Sciences
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
Latest News
Showing market-wide stock news
Why is the US Dollar firm when the Federal Reserve hike is already fully priced in?
5% Treasury yields mean America’s debt bill just got a lot bigger
US30 tests 52,140 as 5% Treasury yields rewrite the equity math
Rupee languishes at six-week low ahead of Fed outcome, RBI limits losses
Gold Price Forecast: XAU/USD consolidates below $4,350 ahead of Fed decision
Bond market woes likely a factor for Fed, but intervention seen as unlikely
Related Stocksin Medical Laboratories
Ready to see the live AI view on CAI?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing CAI side-by-side with live signals.